tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TVTX Stock Latest News

Buy Rating for Travere Therapeutics Amid Filspari’s FDA Review and Market Potential
RatingsBuy Rating for Travere Therapeutics Amid Filspari’s FDA Review and Market Potential
22d ago
TVTX
Travere Therapeutics Holds Annual Meeting, Elects Directors
PremiumCompany Announcements
Travere Therapeutics Holds Annual Meeting, Elects Directors
25d ago
8K
TVTX
Buy Rating for Travere Therapeutics: Strong Potential in FSGS Market Amidst Regulatory Milestones and Competitive Edge
PremiumRatings
Buy Rating for Travere Therapeutics: Strong Potential in FSGS Market Amidst Regulatory Milestones and Competitive Edge
25d ago
TVTX
Travere falls 14% to $18.10 after FDA does not grant priority review
PremiumThe Fly
Travere falls 14% to $18.10 after FDA does not grant priority review
25d ago
TVTX
Travere Therapeutics selloff should be bought, says Citi
PremiumThe Fly
Travere Therapeutics selloff should be bought, says Citi
25d ago
TVTX
Buy Rating Reaffirmed for Travere Therapeutics Amid FDA Review and Market Overreaction
PremiumRatingsBuy Rating Reaffirmed for Travere Therapeutics Amid FDA Review and Market Overreaction
25d ago
TVTX
Closing Bell Movers: Applied Materials down over 5% after Q2 results
Premium
The Fly
Closing Bell Movers: Applied Materials down over 5% after Q2 results
26d ago
QSI
AMAT
Travere Therapeutics’ FDA Acceptance for FILSPARI Application
Premium
Company Announcements
Travere Therapeutics’ FDA Acceptance for FILSPARI Application
26d ago
8K
TVTX
Travere Therapeutics announces FDA acceptance of sNDA for Filspari
PremiumThe Fly
Travere Therapeutics announces FDA acceptance of sNDA for Filspari
26d ago
TVTX
Travere Therapeutics: Strong Market Position and Growth Potential Drive Buy Rating
PremiumRatings
Travere Therapeutics: Strong Market Position and Growth Potential Drive Buy Rating
1M ago
TVTX
Travere Therapeutics’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Travere Therapeutics’ Earnings Call: Growth Amid Challenges
1M ago
TVTX
Travere Therapeutics Reports Strong Q1 2025 Financial Results
PremiumCompany Announcements
Travere Therapeutics Reports Strong Q1 2025 Financial Results
1M ago
TVTX
Strong Market Performance and Growth Potential Drive Buy Rating for Travere Therapeutics
PremiumRatingsStrong Market Performance and Growth Potential Drive Buy Rating for Travere Therapeutics
1M ago
TVTX
Travere Therapeutics reports Q1 adjusted EPS (19c), consensus (39c)
Premium
The Fly
Travere Therapeutics reports Q1 adjusted EPS (19c), consensus (39c)
1M ago
TVTX
Travere, CSL Vifor report EC approval of Filspari for IgA nephropathy
Premium
The Fly
Travere, CSL Vifor report EC approval of Filspari for IgA nephropathy
1M ago
TVTX
Travere, CSL Vifor announce EC approval of Filspari marketing authorization
PremiumThe Fly
Travere, CSL Vifor announce EC approval of Filspari marketing authorization
1M ago
TVTX
TVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
TVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
TVTX
Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
PremiumMarket News
Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
2M ago
CATX
INDI
Travere Therapeutics price target lowered to $30 from $32 at Scotiabank
PremiumThe Fly
Travere Therapeutics price target lowered to $30 from $32 at Scotiabank
2M ago
TVTX
Travere Therapeutics price target raised to $47 from $45 at Canaccord
PremiumThe FlyTravere Therapeutics price target raised to $47 from $45 at Canaccord
2M ago
TVTX
Travere Therapeutics price target lowered to $27 from $31 at BofA
Premium
The Fly
Travere Therapeutics price target lowered to $27 from $31 at BofA
2M ago
NVS
TVTX
Travere Therapeutics price target raised to $31 from $29 at BofA
Premium
The Fly
Travere Therapeutics price target raised to $31 from $29 at BofA
2M ago
TVTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >